Trends in the Hospital Care of Neonates With Hypoplastic Left Heart Syndrome in the United States

美国新生儿左心发育不全综合征住院治疗趋势

阅读:2

Abstract

BACKGROUND: Surgical outcomes of first-stage palliation for hypoplastic left heart syndrome (HLHS) are vastly improved from prior eras and are well described, but rates and determinants of nonsurgical management are understudied, particularly on the national scale. METHODS: The Pediatric Health Information System database was used to identify all index neonatal HLHS admissions between 2015 and 2021 in the United States. Surgical palliation included cardiac surgery and transplantation during the index admission. Multivariable binary logistic regression was used to identify factors independently predictive of nonsurgical management, represented by odds ratio <1.0. RESULTS: In total, 3902 HLHS neonatal admissions to 48 tertiary care centers occurred. Eighteen percent (n = 710) of neonates did not receive surgical palliation. Ninety-seven percent of nonsurgical patients died in the hospital or were discharged to comfort care, whereas 84% of surgically palliated neonates survived to discharge. Nonsurgical patients had greater rates of prematurity, birth weight <2.5 kg, female sex, and chromosomal abnormality (all P < .01). Factors independently associated with nonoperative management included admission to a low-volume surgical program (odds ratio, 0.2 [95% CI, 0.15-0.26]), birth weight <2.5 kg (0.30 [0.24-0.37]), chromosomal abnormality (0.55 [0.43-0.71]), and non-White race/ethnicity (0.68 [0.56-0.82]). CONCLUSIONS: In the contemporary era of neonatal HLHS management, nearly one-fifth of neonates do not undergo surgical palliation in the United States. Additional work can outline the precise reasons underlying such high rates of nonoperative management in hopes of ensuring equitable care for all children with HLHS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。